What is the CAMEO organoid sensor? Researchers have created a low-cost, carbon nanotube-based microelectrode array to monitor ...

Researchers have demonstrated a new class of low-cost, scalable sensors that can be used to monitor electrical activity in ...

NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE), today announced that the first patient has been dosed in the pivotal Phase 3 Aspire study (NCT06617429) ...

Researchers have demonstrated a new class of low-cost, scalable sensors that can be used to monitor electrical activity in ...

Ultragenyx Pharmaceutical Inc. announced the dosing of the first patient in its Phase 3 Aspire study, which is investigating the safety and efficacy of GTX-102, an investigational antisense ...